Prostate cancer (PCa) and type 2 diabetes mellitus (T2DM) are prevalent conditions that often occur concomitantly. However, many aspects of the impact of T2DM, particularly the duration of T2DM and antidiabetic medications, on PCa risk are poorly understood. | Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer A population-based casecontrol study